SNP genotyping using TaqMan® technology: The CYP2D6∗17 assay conundrum

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Gaedigk, Andrea ^a,b   Freeman, Natalie ^c   Hartshorne, Toinette ^d   Riffel, Amanda K ^a   Irwin, David ^c   Bishop, Jeffrey R ^e   Stein, Mark A ^f   Newcorn, Jeffrey H ^g   Jaime, Lazara Karelia Montané ^h   Cherner, Mariana ⁱ   Leeder, J Steven ^a,b  

^a Division of Clinical Pharmacology   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d Thermo Fisher Scientific   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; PRIMER DNA;

ALLELE; BINDING SITE; DNA SEQUENCE; GENETICS; GENOTYPE; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BASE SEQUENCE; BINDING SITES; CYTOCHROME P-450 CYP2D6; DNA PRIMERS; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

EID: 84925355595     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09257     Document Type: Article

References (24)

1. Zhou, S. F. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin. Pharmacokinet 48, 689-723 (2009).
2. Zhou, S. F. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin. Pharmacokinet 48, 761-804 (2009).
3. Zanger, U. M., Turpeinen, M., Klein, K. & Schwab, M. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal. Bioanal. Chem. 392, 1093-1108 (2008).
4. Teh, L. K. & Bertilsson, L. Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance. Drug Metab. Pharmacokinet 27, 55-67 (2012).
5. Zanger, U. M., Raimundo, S. & Eichelbaum, M. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn-Schmiedeberg's Arch. Pharmacol. 369, 23-37 (2004).
6. Drozda, K., Müller, D. J. & Bishop, J. R. Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options. Pharmacotherapy 34, 166-184 (2014).
7. Müller, D. J., Kekin, I., Kao, A. C. & Brandl, E. J. Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic. Int. Rev. Psych. 25, 554-571 (2013).
8. Leppert, W. CYP2D6 in the metabolism of opioids for mild to moderate pain. Pharmacology 87, 274-285 (2011).
9. Trescot, A. M. Genetics and implications in perioperative analgesia. Best practice & research. Clin. Anaesth. 28, 153-166 (2014).
10. Madadi, P., Avard, D. & Koren, G. Pharmacogenetics of opioids for the treatment of acute maternal pain during pregnancy and lactation. Curr. Drug Metab. 13, 721-727 (2012).
11. Hicks, J. K. et al. Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin. Pharmacol. Ther. 93, 402-408 (2013).
12. Crews, K. R. et al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin. Pharmacol. Ther. 95, 376-382 (2014).
13. Gaedigk, A. Complexities of CYP2D6 gene analysis and interpretation. Int. Rev. Psych. 25, 534-553 (2013).
14. Hicks, J. K., Swen, J. J. & Gaedigk, A. Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization. Curr. Drug Metab. 15, 218-232 (2014).
15. Pharmacogenomics Knowledge Base (PharmGKB) Genetic Tests, accessed 09-19-2014. www.Pharmgkb.Org/resources/forscientificusers/pharmacogenomic-tests.Jsp.
16. National Center for Biotechnology Information (NCBI) Genetic Testing Registry, accessed 09-19-2014. www.ncbi.nlm.nih.gov/gtr/tests/?term=cyp2d6.
17. Drug Metabolism Enzyme (DME) Genotyping with Real-Time PCR, Life Technologies, accessed 09-19-2014. www.lifetechnologies.com/us/en/home/life-science/pcr/real-time-pcr/real-time-pcr-applications/genetic-variation-analysis-using-real-time/drug-metabolism-enzymes-profiling-with-real-time-pcr.html.
18. Welch, R. A. et al. Validation of the performance of a comprehensive genotyping assay panel of single nucleotide polymorphisms in drug metabolism enzyme genes. Hum. Mut. 29, 750-756 (2008).
19. TaqMan® SNP Genotyping Assays User Guide. Thermo Fisher Scientific (2014). Accessed 09-19-2014. https://tools.lifetechnologies.com/content/sfs/manuals/TaqMan-SNP-Genotyping-Assays-man.pdf.
20. The Human Cytochrome P450 (CYP) Allele Nomenclature Database, accessed 09-19-2014. www.cypalleles.ki.se/.
21. Friedrich, D. C. et al. Distribution of CYP2D6 alleles and phenotypes in the Brazilian population. PLoS One 9, e110691 (2014).
22. Montane Jaime, L. K., Lalla, A., Steimer, W. & Gaedigk, A. Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants. Pharmacogenomics 14, 261-276 (2013).
23. Gaedigk, A. et al. Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events. Clin. Pharmacol. Ther. 81, 242-251 (2007).
24. Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415 (2003).